REDWOOD CITY, Calif.--(BUSINESS WIRE)--Dextera Surgical Inc. (Nasdaq:DXTR), manufacturer of the smallest-profile and most maneuverable articulating surgical stapling platform on the market for minimally invasive surgery, and B. Braun Surgical S.A., the distribution arm of the B. Braun Aesculap Group, today announced the completion of a video-assisted thoracic surgery (VATS) symposium detailing the use and benefits of the MicroCutter 5/80 Stapler with complementary VATS instrumentation from B. Braun Surgical S.A. for surgeons in Spain.
“This symposium provided an excellent opportunity for surgeons to learn video-assisted thoracic surgery techniques with the latest offerings in cutting-edge technology,” commented Raul Embun, M.D., Ph.D., associate professor of surgery at the Universitario Miguel Servet in Zaragoza, Spain. “Following a productive and engaging session, the surgeons are excited to take the new learnings back to their hospitals and to consider how these new devices may enable less invasive approaches to thoracic surgery.”
Held in Tuttlingen, Germany, at the headquarters of B Braun/Aesculap, 48 surgeons from 24 institutions performing video-assisted thoracic surgery in Spain attended. The symposium included a lecture from Shanda Blackmon, M.D., M.P.H., associate professor of thoracic surgery at the Mayo Clinic, on segmentectomy and other complicated VATS techniques, which highlighted the use of the MicroCutter 5/80 to help enable these procedures. William Walker, F.R.C.S., surgeon at the Royal Infirmary of Edinburgh, presented the posterior approach for VATS lobectomy, also using the MicroCutter 5/80 to help enable the procedure. Dr. Embun presented information on VATS lobectomy, highlighting the first cases using the MicroCutter 5/80 in Spain. Following the demonstrations, all attending surgeons participated in a hands-on simulated lobectomy using Dextera Surgical’s MicroCutter 5/80 as well as B. Braun’s EinsteinVision® 3D camera system and the Caiman® Advanced Bipolar Seal and Cut Technology.
“We are extremely pleased to partner with B. Braun Surgical S.A. to bring the MicroCutter 5/80 to surgeons in Spain,” said Julian Nikolchev, president and CEO of Dextera Surgical. “This symposium, with surgeons from nearly half of all VATS centers in Spain, is a key step in educating surgeons on the benefits of our surgical stapler in Spain and demonstrates the strong fit of the MicroCutter technology with B. Braun’s capabilities and surgical instrument offerings. We were excited to see the positive reaction from the surgeons and their interest in evaluating the MicroCutter 5/80 in Spain.”
In October 2016, Dextera Surgical entered into a marketing and distribution agreement with B. Braun Surgical S.A. whereby B. Braun Surgical S.A. will sell the MicroCutter 5/80 in Spain. B. Braun Surgical S.A. has an extensive network of direct and indirect sales representatives in Spain who focus on surgeons performing minimally invasive surgical procedures.
MicroCutter Indication Information
The MicroCutter 5/80 Stapler is manufactured and cleared for use in the United States for transection and resection in multiple open or minimally invasive urologic, thoracic and pediatric surgical procedures, as well as application for transection, resection and/or creation of anastomoses in the small and large intestine, and the transection of the appendix. The MicroCutter 5/80 may be used with both MicroCutter 30 White Reloads in vascular/thin tissue and MicroCutter 30 Blue Reloads for standard tissue.
About Dextera Surgical
Dextera Surgical (Nasdaq:DXTR) designs and manufactures proprietary stapling devices for minimally invasive surgical procedures. In the U.S., surgical staplers are routinely used in more than one million minimally invasive laparoscopic, video-assisted or robotic-assisted surgical procedures annually.
Dextera Surgical also markets the only automated anastomosis devices for coronary artery bypass graft (CABG) surgery on the market today: the C-Port® Distal Anastomosis Systems and PAS-Port® Proximal Anastomosis System. These products, sold by Dextera Surgical under the Cardica brand name, have demonstrated long-term reliable clinical performance for more than a decade.
The statements in this press release regarding Dextera Surgical’s expectations as to the benefits of using the MicroCutter 5/80 and expectations that the symposium will be key to educating surgeons on the benefits of the surgical stapler in Spain are "forward-looking statements." There are a number of important factors that could cause Dextera Surgical’s results to differ materially from those indicated by these forward-looking statements, including the risks detailed from time to time in Dextera Surgical’s reports filed with the U.S. Securities and Exchange Commission, including its Quarterly Report on Form 10-Q for the quarter ended December 31, 2016, under the caption “Risk Factors.” Dextera Surgical expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein. You are encouraged to read Dextera Surgical’s reports filed with the U.S. Securities and Exchange Commission, available at www.sec.gov.